Every Thursday we send out a curated newsletter on all things femtech and women’s health innovation. This is an excerpt from the latest edition. If you’d like to subscribe, you can do so at the bottom of this page.
Highlights
Pharma company MEDICE Health Familyacquires German menopause app femfeel.
The ASRM announces $5M endowment from Ferring.
The FDA establishes a new advisory committee on digital health technologies (and YOU can be a part of it!)
Gameto‘s In Vitro Maturation Candidate Fertilo shows potential in improving reproductive technology.
Diaper startup Hello Bello files for bankruptcy.
Maternal health startup Oula opens third clinic; announces expansion of its partnership with Mount Sinai.
Ulta Beauty partners with SOS for In-Store Product Sampling.
Health Canada approves MYFEMBREE for the treatment of endometriosis and uterine fibroids.
Blue Cross and Blue Shields of Texas partners with Delfina and InovCares to Advance Maternal Health.
CurE-me Project joins BII‘s Bio Studio to advance human disease models specific to endometriosis.
In the Know
Is Metabolic Health the Next Big Thing in Women’s Health? (Femtech Insider)
INTIMINA Highlights Period Poverty on Campuses: 20% of Students Face Difficult Choices Over Menstrual Product Costs (Femtech Insider)
Women face host of disadvantages in cancer prevention and care, report finds (STAT News)
What’s driving more women to quit birth control? (Axios)
Should Venture Capital Invest in Digital Health (Venturing into Healthcare / Substack)
Q3 Data for Female Founders Is Just More of the Same (TechCrunch)
Were midwives the OG witches? How the history of mystic medicine and reproductive health intertwine? (Salon)
The Calendar of Human Fertility Is Changing (The Atlantic)
